Axon Clinical
Clinical research center conducting trials for pharmaceutical, biotechnology and CRO partners
Highlights
- New on EvolcAdded 2026-11-08
About Axon Clinical
Axon Clinical operates a clinical research center with GCP-trained staff, coordinators and infrastructure for human clinical research. It conducts Phase I–IV trials, including early-phase and proof-of-concept studies in adults and children, and provides support with regulatory and ethics submissions.
Its partners include pharmaceutical and biotechnology companies and contract research organizations. The company is based in Prague, Czech Republic, and was founded in 2009.
Product: Clinical trial conduct and related operational and regulatory support, including access to a local ethics committee.
Jobs at Axon Clinical
Leadership
- Martin Wallisch · Jednatel (Managing director)Source: business register
- Vladimír Strasmajer · Jednatel (Managing director)Source: business register
More health & medtech companies
AZX
Supplier of X-ray equipment, servicing and radiation-protection services for medical and veterinary imaging rooms in the Czech RepublicBaculus, o.p.s.
Residential elder care and special-regime services for seniors in Vejprnice, Czech RepublicNew on Evolcbamed
Laboratory equipment, consumables and servicing for pathology, histology and related laboratoriesNew on Evolcbandingklub.cz
Civic association providing information on bariatric surgery and gastric banding for patients in the Czech RepublicBARMED
Adult primary care, preventive screenings and occupational health services for patients and employers in Moravská Nová Ves and LužiceNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.